Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph S Koopmeiners

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Biostatistics (Oxford, England)|October 17, 2017
Bayesian hierarchical modeling based on multisource exchangeabilityAlexander M Kaizer, Joseph S Koopmeiners, Brian P Hobbs
Biometrics|January 24, 2018
A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategiesAlexander M Kaizer, Brian P Hobbs, Joseph S Koopmeiners
Biometrics|January 8, 2026
Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trialsJack M Wolf, Joseph S Koopmeiners, David M Vock
Contemporary Clinical Trials|August 20, 2024
Commentary on Chen et al. (2022): The need for continued methodological research on leveraging information in secondary endpoints for more efficient RCTsJack M Wolf, Joseph S Koopmeiners, David M Vock
Clinical Trials (London, England)|May 9, 2022
A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rateJack M Wolf, Joseph S Koopmeiners, David M Vock
Contemporary Clinical Trials|March 10, 2024
Optimal timing for an accelerated interim futility analysis incorporating real world dataLillian M F Haine, Thomas A Murray, Joseph S Koopmeiners
Bayesian Analysis|August 26, 2024
A General Bayesian Functional Spatial Partitioning Method for Multiple Region Discovery Applied to Prostate Cancer MRIMaria Masotti, Lin Zhang, Gregory J Metzger, et al.
Statistics in Medicine|November 10, 2021
A group-sequential randomized trial design utilizing supplemental trial dataAles Kotalik, David M Vock, Brian P Hobbs, et al.
Statistical Methods in Medical Research|December 3, 2020
Statistical design considerations for trials that study multiple indicationsAlexander M Kaizer, Joseph S Koopmeiners, Nan Chen, et al.
Oncology Letters|January 8, 2014
High expression of class III β-tubulin in small cell lung carcinomaSteven Powell, Alex Kaizer, Joseph S Koopmeiners, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Biostatistics (Oxford, England)|October 17, 2017
Bayesian hierarchical modeling based on multisource exchangeabilityAlexander M Kaizer, Joseph S Koopmeiners, Brian P Hobbs
Biometrics|January 24, 2018
A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategiesAlexander M Kaizer, Brian P Hobbs, Joseph S Koopmeiners
Biometrics|January 8, 2026
Jointly modeling multiple endpoints for efficient treatment effect estimation in randomized controlled trialsJack M Wolf, Joseph S Koopmeiners, David M Vock
Contemporary Clinical Trials|August 20, 2024
Commentary on Chen et al. (2022): The need for continued methodological research on leveraging information in secondary endpoints for more efficient RCTsJack M Wolf, Joseph S Koopmeiners, David M Vock
Clinical Trials (London, England)|May 9, 2022
A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rateJack M Wolf, Joseph S Koopmeiners, David M Vock
Contemporary Clinical Trials|March 10, 2024
Optimal timing for an accelerated interim futility analysis incorporating real world dataLillian M F Haine, Thomas A Murray, Joseph S Koopmeiners
Bayesian Analysis|August 26, 2024
A General Bayesian Functional Spatial Partitioning Method for Multiple Region Discovery Applied to Prostate Cancer MRIMaria Masotti, Lin Zhang, Gregory J Metzger, et al.
Statistics in Medicine|November 10, 2021
A group-sequential randomized trial design utilizing supplemental trial dataAles Kotalik, David M Vock, Brian P Hobbs, et al.
Statistical Methods in Medical Research|December 3, 2020
Statistical design considerations for trials that study multiple indicationsAlexander M Kaizer, Joseph S Koopmeiners, Nan Chen, et al.
Oncology Letters|January 8, 2014
High expression of class III β-tubulin in small cell lung carcinomaSteven Powell, Alex Kaizer, Joseph S Koopmeiners, et al.
Pageof 13